EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Oral–Gut–Liver axis: A Novel Link in the Pathogenesis of Metabolic Dysfunction–Associated Steatotic Liver Disease

Sibel Başçıl, Gülay Şimşek Bağır

Endocrinology Research and Practice · 04.08.2026

DOI: 10.5152/erp.2026.26982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology Research and Practice, online erschienen am 04.08.2026. Verfasst von Sibel Başçıl und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a common chronic liver disease worldwide. It has become one of the leading reasons for liver transplants, and it is strongly linked to metabolic syndrome, obesity, insulin resistance, and type 2 diabetes. Despite growing awareness of its clinical impact, the mechanisms that drive MASLD progression to steatohepatitis and cirrhosis are not fully understood, and there is currently no approved medication to stop disease progression. Recent studies indicate that oral health issues, especially periodontal disease, may influence the progression and severity of MASLD. Periodontal disease, especially periodontitis, is a chronic inflammatory condition affecting the supporting structures of the teeth and is increasingly recognized as a potential contributor to systemic diseases. Recent research shows a notable link between MASLD and periodontal disease, driven by shared metabolic risk factors, chronic systemic inflammation, and microbial imbalance. The oral–gut–liver axis has emerged as a potential biological mechanism linking periodontal pathogens to liver inflammation and metabolic disorders. This narrative review summarizes current epidemiological evidence, explores the biological mechanisms behind the link between MASLD and periodontal disease, and discusses potential clinical implications for integrated patient care. Cite this article as: Bascil S, Bağır GŞ. Oral–gut–liver axis: A novel link in the pathogenesis of metabolic dysfunction– associated steatotic liver disease. Endocrinol Res Pract. Published online August 1, 2026. doi: 10.5152/erp.2026.26982.

Zitieren

APA

Başçıl, S., & Bağır, G. Ş. (2026). Oral–Gut–Liver axis: A Novel Link in the Pathogenesis of Metabolic Dysfunction–Associated Steatotic Liver Disease. Endocrinology Research and Practice. https://doi.org/10.5152/erp.2026.26982

Vancouver

Başçıl S, Bağır GŞ. Oral–Gut–Liver axis: A Novel Link in the Pathogenesis of Metabolic Dysfunction–Associated Steatotic Liver Disease. Endocrinology Research and Practice. 2026. doi:10.5152/erp.2026.26982

BibTeX
@article{Bal2026,
  author = {Başçıl, Sibel and Bağır, Gülay Şimşek},
  title = {Oral–Gut–Liver axis: A Novel Link in the Pathogenesis of Metabolic Dysfunction–Associated Steatotic Liver Disease},
  journal = {Endocrinology Research and Practice},
  year = {2026},
  doi = {10.5152/erp.2026.26982}
}
Kostenlos starten →